Primary Care Diabetes
Volume 2, Issue 3 , Pages 135-140 , September 2008

Prevalence and incidence of chronic complications and mortality in a cohort of type 2 diabetic patients in Spain

Received 15 December 2007 ,Revised 29 March 2008 ,Accepted 1 May 2008.

References 

  1. The World Health Report: life in 21st Century, Ginebra 1991.
  2. Goday A, Serrano Rios M. Epidemiologia de la Diabetes Mellitus en España. Revisión crítica y nuevas prespectivas. Med. Clin. (Barc.). 1994;41:301–304
  3. Medrano MJ, Cerrato E, Boix R, Delgado-Rodriguez M. Factores de riesgo cardiovascular en la población española: metaanálisis de estudios transversales. Med. Clin. (Barc.). 2005;1241:606–612
  4. Morgan CL, Curie CJ, Peters JR. Relationship between diabetes and mortality: a population study using record linkage. Diabetes Care. 2003;23:1103–1107
  5. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with Type 2 diabetes. N. Engl. J. Med. 2003;348:383–393
  6. American Diabetes Association. Clinical Practice Recommendation 2006. Diabetes Care. 2006;29:S1–S135
  7. GEDAPS. Guia para el tratamiento de la Diabetes Mellitus tipo 2 en Atención Primaria. Harcourt, Barcelona 2004.
  8. Nazimek-Siewniak B, Moczulski D, Grzeszczak W. Risk of macrovascular and microvascular complications in type 2 diabetes. Results of longitudinal study design. J. Diabetes Complications. 2002;16:271–2769
  9. C. Brotons, R. Ciurana, A. Franzi, R.M. Garcia, A. Isach, J. Tobías, J. Vilaseca. Hipercolesterolemia, Guia Pràctica clínica. Intitut Català de la Salut 2001.
  10. McAlpine R, Morris AD, Emslie-Smith A, et al. The annual inicdence of diabetic complications in population of patients with Type 1 and Type 2 diabetes. Diabetic Med. 2004;22:348–352
  11. Younis N, Broadbent DM, Vora JP, Harding SP. Incidence of sight-treatening retinopathy with type 2 diabetes in the Liverpool Diabetic Eye study: a cohort study. Lancet. 2003;361:195–200
  12. Fox CS, Coady S, Sorlie PD, et al. Trends in Cardiovascular complications of diabetes. JAMA. 2004;292:2495–2499
  13. Artegoitia JM, Larrañaga MI, Rodríguez JL, et al. Incidente, prevalence and coronary heart disease risk level in knowm Type 2 diabetes: a sentinel practice network study in the Basque Country, Spain. Diabetologia. 2003;46:899–909
  14. Liebl A, Neiss A, Spannheimer A, et al. Complications, co-morbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany—results from the CODE-2 study. Exp. Clin. Endocrinol. Diabetes. 2002;110:10–16
  15. Grimaldi A, Grange V, Allannic H, et al. Epidemiological analysis of patients with Type 2 diabetes in France. J. Diabetes Complications. 2000;14:242–249
  16. Farnkvist LM, Lundiabetesan BM. Outcomes of diabetes care: a population-based study. Int. J. Quality Health Care. 2003;15:301–307
  17. Mundet X, Carmona F, Gussinyer P, et al. Complicaciones crónicas de la Diabetes Mellitus tipo 2. Evolución tras 5 años de seguimiento. Aten. Primaria. 2000;25:405–411
  18. Mur T, Franch J, Morató J, et al. Macroangiopatia en la diabetes tipo 2. Aten. Primaria. 1995;16:67–72
  19. UK Prospective Diabetes study 23: risk factors for coronary artery disease in non-insulin dependent diabetes. Br. Med. J. 1998;316:823–828
  20. Turner RC, Cull CA, Frighi V, Holman RR. UKPDS 49 Glycaemic control with diet, sulphonylurea, metformin and insulin therapy in patients with type 2 diabetes: progressive requirement for multiple therapies. JAMA. 1999;281:2005–2012
  21. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N. Engl. J. Med. 1999;341:1127–1133
  22. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes. 1994;43:960–967
  23. Lehto S, Ronnemaa T, Haffner SM, et al. Dislipemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes. 1997;48:1354–1359
  24. Khaw K, Wareham N, Luben R, et al. Glycated haemoglobina,diabetes, and mortality in men in Norfolk cohort of European prospective Investigation of Cancer and nutrition (EPIC-Norfolk). Br. Med. J. 2001;322:1–6
  25. Wei M, Gaskill SP, Haffner SM, Stern MP. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care. 1998;21:1167–1172
  26. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosilated hemoglobin and cardiovascular disease in diabetes mellitus. Ann. Intern. Med. 2004;141:421–431
  27. Fox CS, Sullivan L, D’Agostino RB, Wilson PW. The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart study. Diabetes Care. 2004;27:704–708
  28. Thomas RJ, Palumbo PJ, Melton LJ, et al. Trends in the mortality burden associated with diabetes mellitus. A population-based study in Rochester, Minn, 1970–1994. Arch. Intern. Med. 2003;163:445–451
  29. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors amb 12 year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 1993;16:434–444
  30. Cusik M, Meleth AD, Agron E, et al. Associations of mortality and diabetes complications in patients with type 1 and Type 2 diabetes. Early Treatment Diabetic Retinopathy Study report no 27. Diabetes Care. 2005;28:617–625
  31. P. Roura P. Evaluación de los indicadores de calidad asistencial al diabético tipo 2 en el ámbito urbano i no urbano. 10 años de experiencia de programa GEDAPS. Tesis Doctoral. Universidad Autónoma de Barcelona, Barcelona 2006.
  32. Wandell PE, Gafvels C. Patients with type 2 diabetes aged 35–64 years at four primary health centres in Stockholm Country, Sweden prevalence and complications in relation to gender and socio-economics status. Diabetes Res. Clin. Prac. 2004;63:195–203

PII: S1751-9918(08)00058-2

doi: 10.1016/j.pcd.2008.05.001

Primary Care Diabetes
Volume 2, Issue 3 , Pages 135-140 , September 2008

Article Tools